Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
22
SAGE
Sage Therapeutics
Last Price:
5.94
Seasonality Move:
19.95%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.92 | Sell |
20-day SMA: | 7.04 | Sell |
50-day SMA: | 7.31 | Sell |
200-day SMA: | 13.26 | Sell |
8-day EMA: | 6.56 | Sell |
20-day EMA: | 6.97 | Sell |
50-day EMA: | 7.55 | Sell |
200-day EMA: | 12.91 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | 538073 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.25 - 7.75) | Sell |
Bollinger Bands (100): | (6.93 - 10.73) | Sell |
Sage Therapeutics Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 5.94 while SAGE 8-day simple moving average is 6.92, which is a Sell signal.
- The stock price of SAGE is 5.94 while Sage Therapeutics 20-day SMA is 7.04, which makes it a Sell.
- Sage Therapeutics 50-day simple moving average is 7.31 while SAGE share price is 5.94, making it a Sell technically.
- SAGE stock price is 5.94 and Sage Therapeutics 200-day simple moving average is 13.26, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $5.94. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
363.37M
Price in USD:
5.94
Share Volume:
575.18K
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
5.64
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 5.94 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 5.94 while SAGE 8-day exponential moving average is 6.56, which is a Sell signal.
- The stock price of SAGE is 5.94 while Sage Therapeutics 20-day EMA is 6.97, which makes it a Sell.
- Sage Therapeutics 50-day exponential moving average is 7.55 while SAGE share price is 5.94, making it a Sell technically.
- SAGE stock price is 5.94 and Sage Therapeutics 200-day simple moving average is 12.91, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $2.10 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 34.97, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (6.25 - 7.75), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (6.93 - 10.73), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.